+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Copovidone Market - Global Forecast to 2030- Product Image
Copovidone Market - Global Forecast to 2030- Product Image
Sale

Copovidone Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 183 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6157858
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The executive summary offers a succinct yet comprehensive overview of copovidone’s evolving role in pharmaceutical development. In this introduction, we outline key themes and strategic considerations that emerge from a detailed assessment of copovidone’s technical attributes, market dynamics, and regulatory headwinds. By framing the discussion around innovation in formulation, shifts in global trade policy, and segmentation-driven growth, this summary equips decision-makers with a clear understanding of current trends and future opportunities. The subsequent sections delve into transformative shifts in the landscape, examine the cumulative impact of upcoming U.S. tariffs, and highlight segmentation and regional insights that inform targeted strategies. Finally, actionable recommendations will guide industry leaders in optimizing their product pipelines, supply chains, and partnerships, while the conclusion and call-to-action encourage engagement with a comprehensive research report tailored to drive competitive advantage.

Transformative Shifts Shaping the Copovidone Landscape

Copovidone’s landscape has undergone remarkable transformation in recent years, driven by advances in formulation science and evolving therapeutic needs. The rise of patient-centric dosage forms and personalized therapy solutions has propelled copovidone from a conventional binder and film former to a versatile excipient that supports oral films, poorly soluble APIs, and innovative drug delivery platforms. Simultaneously, sustainability imperatives have incentivized manufacturers to adopt greener production processes, reducing solvent use and minimizing environmental footprint.

These converging forces have fostered competitive differentiation. Companies have intensified research on hot melt extrusion and solubilization techniques, unlocking opportunities for enhancing bioavailability and taste masking. Meanwhile, integration of copovidone into oral film and 3D printing applications underscores its adaptability in cutting-edge dosage innovations. As a result, copovidone now occupies a critical nexus where formulation flexibility, regulatory compliance, and patient experience intersect. In the next section, we examine how impending U.S. tariff changes will shape supply chain strategies and cost structures across the industry.

Analyzing the Cumulative Impact of United States Tariffs 2025

The announcement of new U.S. tariffs set to take effect in 2025 will reverberate throughout the copovidone supply chain. These measures, targeting key raw material imports and intermediates used in copovidone synthesis, will elevate production costs for domestic manufacturers and their contract development partners. In anticipation, several stakeholders have begun diversifying supply sources, securing long-term contracts with non-U.S. suppliers, and exploring backward integration to stabilize margin pressures.

Moreover, the tariff structure has prompted reassessment of logistical networks. Companies are evaluating alternative shipping routes, optimizing inventory positioning, and leveraging free trade zones to mitigate duty exposure. Firms that proactively adjust procurement strategies can shield product pipelines from abrupt cost increases, preserving the economics of thin film and hot melt extrusion processes. Critical to this effort is close collaboration with suppliers and logistics experts to negotiate favorable terms and identify duty-deferral opportunities. As the landscape adapts, organizations that demonstrate agility in tariff response will gain a competitive edge.

Key Segmentation Insights Across Formulation, Application, and Technology

Segmentation analysis reveals nuanced growth drivers and application niches within the copovidone market. Based on formulation techniques, the direct compression segment stands out for its role in streamlined tablet manufacturing and innovative tablet design, enabling dose flexibility and rapid development timelines. Film coating has become essential for taste masking applications, enhancing patient compliance in pediatric and geriatric populations. Meanwhile, hot melt extrusion, with its enhanced solubility methods, unlocks new possibilities for poorly water-soluble APIs and controlled-release profiles.

Turning to functional applications, the adhesive binder category underpins tablet binders that ensure content uniformity and robust tablet hardness. Copovidone’s film former capabilities have gained prominence in oral films, offering rapid dissolution and versatile dosing for sublingual and buccal delivery. Its solubilizer function contributes significantly to improved bioavailability, a critical factor in second-generation formulations of BCS Class II compounds.

When examining product types, granules maintain their traditional role in wet binder granulation, while oral film dosage, particularly thin films, addresses the demand for discrete, easy-administered formats. Oral solid dosage forms, notably capsules and tablets, continue to represent the backbone of pharmaceutical portfolios, benefiting from copovidone’s binding and release-modifying attributes.

Finally, innovative technologies such as 3D printing in pharmaceuticals leverage copovidone for personalized medicine applications, enabling on-demand dose customization. Nanotechnology-enabled systems harness copovidone within targeted delivery platforms, improving therapeutic index and reducing off-target effects. Together, these segmentation insights highlight copovidone’s multifaceted value across formulation approaches and therapeutic objectives.

Key Regional Insights Impacting Copovidone Demand

Regional dynamics further shape copovidone’s market performance. In the Americas, robust biopharma activity and strong generics penetration drive steady demand, while manufacturers benefit from proximity to leading API producers and contract facilities. North American firms are increasingly investing in advanced granulation and extrusion capabilities to address evolving dosage requirements.

Europe, Middle East & Africa present a diverse regulatory landscape with high standards for excipient quality and sustainability. In Western Europe, stringent environmental regulations have encouraged adoption of solvent-less processes, positioning copovidone as a preferred binder in green manufacturing initiatives. Emerging markets in the Middle East and Africa offer growth potential as local production scales up to meet rising healthcare needs.

Asia-Pacific remains the fastest-growing region, fueled by expanding pharmaceutical production in China, India, and Southeast Asia. Competitive manufacturing costs and government incentives for generics and biosimilars accelerate copovidone utilization in formulation innovation. Partnerships between local producers and global excipient providers are on the rise, facilitating technology transfer and capacity expansion.

Key Company Insights in the Copovidone Ecosystem

The competitive landscape features a blend of global chemical giants and specialized excipient providers. Ashland Global Holdings Inc., BASF SE, and Dow Chemical Company leverage extensive R&D capabilities and integrated supply chains to offer high-purity copovidone grades. Evonik Industries AG, Lonza Group AG, and Mitsubishi Chemical Corporation contribute deep expertise in advanced polymer science and regulatory compliance.

In parallel, Colorcon, Inc., JRS Pharma Limited, and Lubrizol Corporation focus on film forming and taste masking, developing tailored solutions for oral films and coatings. Polysciences, Inc. and PrimePoly Inc. address niche demands for enhanced bioavailability, while PolMerex Inc. and PharmaPolymer Solutions Inc. drive innovation in hot melt extrusion and nanoparticle dispersion.

Mid-sized companies such as ChemPol Solutions, Clariant AG, Cognis Corporation, and Roquette Frères differentiate through agile production models and customer-centric service. DPI Corporation and DuoPharma International support custom granulation and contract manufacturing services. Excipio Technologies, Fagron NV, Global Excipients Group, InterExcipients Corporation, LUCI Pharma Inc., MedChemEx Industries, NexGen Polymers LLC, NovaChem Excipients Ltd., and TriMed Solutions specialize in tailor-made excipient development, addressing emerging formulation challenges.

This diverse ecosystem fosters collaboration and competitive benchmarking, enabling pharmaceutical developers to select partners based on technical expertise, geographic reach, and regulatory track record.

Actionable Recommendations for Industry Leaders

To capitalize on copovidone’s versatility and navigate evolving market conditions, industry leaders should pursue four strategic priorities. First, strengthen supply chain resilience by diversifying raw material sourcing and negotiating multi-year agreements with key suppliers. This approach mitigates tariff risk and ensures uninterrupted access to high-quality copovidone.

Second, invest in platform technologies that leverage copovidone’s unique properties. Expanding hot melt extrusion capabilities and integrating 3D printing into formulation pipelines can accelerate time-to-market and support personalized dosage forms. Collaboration with technology partners and academic centers will amplify innovation.

Third, deepen end-market engagement through targeted partnerships. Aligning with CDMOs and specialty manufacturers in high-growth regions-particularly Asia-Pacific-will unlock new application areas and expedite regulatory filings. Joint development agreements can fast-track novel oral film and nanodelivery projects.

Finally, champion sustainability and regulatory excellence by implementing solvent-free processes, minimizing waste, and securing excipient master file approvals in key jurisdictions. Demonstrating environmental stewardship and compliance leadership enhances brand reputation and fosters long-term customer loyalty.

Conclusion and Strategic Outlook

This executive summary has highlighted copovidone’s strategic importance across formulation techniques, functional applications, and product innovations. It also underscored how U.S. tariff changes will influence cost structures and supply chain strategies. Regional and company-level insights reveal a dynamic ecosystem where global chemical majors and specialized providers collaborate to meet diverse pharmaceutical needs.

Moving forward, stakeholders who embrace segmentation-driven innovation, bolster supply chain agility, and forge targeted partnerships will be best positioned to harness copovidone’s full potential. Commitment to sustainability and regulatory excellence will further differentiate leaders in an increasingly competitive landscape. We encourage readers to explore detailed analyses and supplemental data to refine their strategies and achieve robust growth.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Formulation Techniques
    • Direct Compression
      • Innovative Tablet Design
    • Film Coating
      • Taste Masking Applications
    • Hot Melt Extrusion
      • Enhanced Solubility Methods
  • Functional Applications
    • Adhesive Binder
      • Tablet Binders
    • Film Former
      • Oral Films
    • Solubilizer
      • Improved Bioavailability
  • Product Types
    • Granules
    • Oral Film Dosage
      • Thin Films
    • Oral Solid Dosage
      • Capsules
      • Tablets
  • Innovative Technologies
    • 3D Printing In Pharmaceuticals
      • Personalized Medicine
    • Nanotechnology Enabled Systems
      • Targeted Delivery
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom
This research report delves into recent significant developments and analyzes trends in each of the following companies:
  • Ashland Global Holdings Inc.
  • BASF SE
  • ChemPol Solutions
  • Clariant AG
  • Cognis Corporation
  • Colorcon, Inc.
  • Dow Chemical Company
  • DPI Corporation
  • DuoPharma International
  • Eastman Chemical Company
  • Evonik Industries AG
  • Excipio Technologies
  • Fagron NV
  • Global Excipients Group
  • InterExcipients Corporation
  • JRS Pharma Limited
  • Lonza Group AG
  • Lubrizol Corporation
  • LUCI Pharma Inc.
  • MedChemEx Industries
  • Mitsubishi Chemical Corporation
  • NexGen Polymers LLC
  • NovaChem Excipients Ltd.
  • PharmaPolymer Solutions Inc.
  • PolyMerex Inc.
  • Polysciences, Inc.
  • PrimePoly Inc.
  • Roquette Frères
  • Solvay S.A.
  • TriMed Solutions

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Copovidone Market, by Formulation Techniques
8.1. Introduction
8.2. Direct Compression
8.2.1. Innovative Tablet Design
8.3. Film Coating
8.3.1. Taste Masking Applications
8.4. Hot Melt Extrusion
8.4.1. Enhanced Solubility Methods
9. Copovidone Market, by Functional Applications
9.1. Introduction
9.2. Adhesive Binder
9.2.1. Tablet Binders
9.3. Film Former
9.3.1. Oral Films
9.4. Solubilizer
9.4.1. Improved Bioavailability
10. Copovidone Market, by Product Types
10.1. Introduction
10.2. Granules
10.3. Oral Film Dosage
10.3.1. Thin Films
10.4. Oral Solid Dosage
10.4.1. Capsules
10.4.2. Tablets
11. Copovidone Market, by Innovative Technologies
11.1. Introduction
11.2. 3D Printing In Pharmaceuticals
11.2.1. Personalized Medicine
11.3. Nanotechnology Enabled Systems
11.3.1. Targeted Delivery
12. Americas Copovidone Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Copovidone Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Copovidone Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Ashland Global Holdings Inc.
15.3.2. BASF SE
15.3.3. ChemPol Solutions
15.3.4. Clariant AG
15.3.5. Cognis Corporation
15.3.6. Colorcon, Inc.
15.3.7. Dow Chemical Company
15.3.8. DPI Corporation
15.3.9. DuoPharma International
15.3.10. Eastman Chemical Company
15.3.11. Evonik Industries AG
15.3.12. Excipio Technologies
15.3.13. Fagron NV
15.3.14. Global Excipients Group
15.3.15. InterExcipients Corporation
15.3.16. JRS Pharma Limited
15.3.17. Lonza Group AG
15.3.18. Lubrizol Corporation
15.3.19. LUCI Pharma Inc.
15.3.20. MedChemEx Industries
15.3.21. Mitsubishi Chemical Corporation
15.3.22. NexGen Polymers LLC
15.3.23. NovaChem Excipients Ltd.
15.3.24. PharmaPolymer Solutions Inc.
15.3.25. PolyMerex Inc.
15.3.26. Polysciences, Inc.
15.3.27. PrimePoly Inc.
15.3.28. Roquette Frères
15.3.29. Solvay S.A.
15.3.30. TriMed Solutions
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. COPOVIDONE MARKET MULTI-CURRENCY
FIGURE 2. COPOVIDONE MARKET MULTI-LANGUAGE
FIGURE 3. COPOVIDONE MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL COPOVIDONE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL COPOVIDONE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES COPOVIDONE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES COPOVIDONE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. COPOVIDONE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. COPOVIDONE MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. COPOVIDONE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COPOVIDONE MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL COPOVIDONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL COPOVIDONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL COPOVIDONE MARKET SIZE, BY INNOVATIVE TABLET DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL COPOVIDONE MARKET SIZE, BY FILM COATING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL COPOVIDONE MARKET SIZE, BY TASTE MASKING APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL COPOVIDONE MARKET SIZE, BY ENHANCED SOLUBILITY METHODS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL COPOVIDONE MARKET SIZE, BY TABLET BINDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL COPOVIDONE MARKET SIZE, BY FILM FORMER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL COPOVIDONE MARKET SIZE, BY SOLUBILIZER, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL COPOVIDONE MARKET SIZE, BY IMPROVED BIOAVAILABILITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL COPOVIDONE MARKET SIZE, BY GRANULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL COPOVIDONE MARKET SIZE, BY THIN FILMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL COPOVIDONE MARKET SIZE, BY CAPSULES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL COPOVIDONE MARKET SIZE, BY TABLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL COPOVIDONE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL COPOVIDONE MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS COPOVIDONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 59. ARGENTINA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 60. ARGENTINA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 61. ARGENTINA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 62. ARGENTINA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 69. ARGENTINA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 70. ARGENTINA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 71. BRAZIL COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 72. BRAZIL COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 85. CANADA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 86. CANADA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 87. CANADA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 88. CANADA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 89. CANADA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 90. CANADA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 91. CANADA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 92. CANADA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 93. CANADA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 94. CANADA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 95. CANADA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 96. CANADA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 97. CANADA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 98. CANADA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 99. MEXICO COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 100. MEXICO COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 101. MEXICO COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 102. MEXICO COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 103. MEXICO COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 104. MEXICO COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 105. MEXICO COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 106. MEXICO COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 107. MEXICO COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 108. MEXICO COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 109. MEXICO COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 110. MEXICO COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 111. MEXICO COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 112. MEXICO COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 113. UNITED STATES COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 114. UNITED STATES COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 115. UNITED STATES COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 116. UNITED STATES COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 117. UNITED STATES COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 118. UNITED STATES COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 119. UNITED STATES COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 120. UNITED STATES COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 121. UNITED STATES COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 122. UNITED STATES COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 123. UNITED STATES COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 124. UNITED STATES COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 125. UNITED STATES COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 126. UNITED STATES COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 127. UNITED STATES COPOVIDONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 128. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 129. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 130. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 131. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 132. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 133. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 134. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 135. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 136. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 137. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 138. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 139. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 140. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 141. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 142. ASIA-PACIFIC COPOVIDONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 143. AUSTRALIA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 144. AUSTRALIA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 145. AUSTRALIA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 146. AUSTRALIA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 147. AUSTRALIA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 148. AUSTRALIA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 149. AUSTRALIA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 150. AUSTRALIA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 151. AUSTRALIA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 152. AUSTRALIA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 153. AUSTRALIA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 154. AUSTRALIA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 155. AUSTRALIA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 156. AUSTRALIA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 157. CHINA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 158. CHINA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 159. CHINA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 160. CHINA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 161. CHINA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 162. CHINA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 163. CHINA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 164. CHINA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 165. CHINA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 166. CHINA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 167. CHINA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 168. CHINA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 169. CHINA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 170. CHINA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 171. INDIA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 172. INDIA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 173. INDIA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 174. INDIA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 175. INDIA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 176. INDIA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 177. INDIA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 178. INDIA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 179. INDIA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 180. INDIA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 181. INDIA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 182. INDIA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 183. INDIA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 184. INDIA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 185. INDONESIA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 186. INDONESIA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 187. INDONESIA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 188. INDONESIA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 189. INDONESIA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 190. INDONESIA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 191. INDONESIA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 192. INDONESIA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 193. INDONESIA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 194. INDONESIA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 195. INDONESIA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 196. INDONESIA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 197. INDONESIA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 198. INDONESIA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 199. JAPAN COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 200. JAPAN COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 201. JAPAN COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 202. JAPAN COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 203. JAPAN COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 204. JAPAN COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 205. JAPAN COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 206. JAPAN COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 207. JAPAN COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 208. JAPAN COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 209. JAPAN COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 210. JAPAN COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 211. JAPAN COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 212. JAPAN COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 213. MALAYSIA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 214. MALAYSIA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 215. MALAYSIA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 221. MALAYSIA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 222. MALAYSIA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 223. MALAYSIA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 224. MALAYSIA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 225. MALAYSIA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 226. MALAYSIA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 227. PHILIPPINES COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 228. PHILIPPINES COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 229. PHILIPPINES COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 230. PHILIPPINES COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 231. PHILIPPINES COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 232. PHILIPPINES COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 233. PHILIPPINES COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 234. PHILIPPINES COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 235. PHILIPPINES COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 236. PHILIPPINES COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 237. PHILIPPINES COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 238. PHILIPPINES COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 239. PHILIPPINES COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 240. PHILIPPINES COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 241. SINGAPORE COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 242. SINGAPORE COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 243. SINGAPORE COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 244. SINGAPORE COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 245. SINGAPORE COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 246. SINGAPORE COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 247. SINGAPORE COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 248. SINGAPORE COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 249. SINGAPORE COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 250. SINGAPORE COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 251. SINGAPORE COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 252. SINGAPORE COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 253. SINGAPORE COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 254. SINGAPORE COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 255. SOUTH KOREA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 256. SOUTH KOREA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 257. SOUTH KOREA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 258. SOUTH KOREA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 259. SOUTH KOREA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 260. SOUTH KOREA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 261. SOUTH KOREA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 262. SOUTH KOREA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 263. SOUTH KOREA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 264. SOUTH KOREA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 265. SOUTH KOREA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 266. SOUTH KOREA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 267. SOUTH KOREA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 268. SOUTH KOREA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 269. TAIWAN COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 270. TAIWAN COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 271. TAIWAN COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 272. TAIWAN COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 273. TAIWAN COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 274. TAIWAN COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 281. TAIWAN COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 282. TAIWAN COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 283. THAILAND COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 284. THAILAND COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 285. THAILAND COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 286. THAILAND COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 287. THAILAND COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 288. THAILAND COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 289. THAILAND COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 290. THAILAND COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 291. THAILAND COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 292. THAILAND COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 293. THAILAND COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 294. THAILAND COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 295. THAILAND COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 296. THAILAND COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 297. VIETNAM COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 298. VIETNAM COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 299. VIETNAM COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 300. VIETNAM COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 301. VIETNAM COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 302. VIETNAM COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 303. VIETNAM COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 304. VIETNAM COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 305. VIETNAM COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 306. VIETNAM COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 307. VIETNAM COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 308. VIETNAM COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 309. VIETNAM COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 310. VIETNAM COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 311. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 312. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 313. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 314. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 315. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 316. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 317. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 318. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 319. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 320. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 321. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 322. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 323. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 324. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 325. EUROPE, MIDDLE EAST & AFRICA COPOVIDONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 326. DENMARK COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 327. DENMARK COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 328. DENMARK COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 329. DENMARK COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 330. DENMARK COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 331. DENMARK COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 332. DENMARK COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 333. DENMARK COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 334. DENMARK COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 335. DENMARK COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 336. DENMARK COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 337. DENMARK COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 338. DENMARK COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 339. DENMARK COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 340. EGYPT COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 341. EGYPT COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 342. EGYPT COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 343. EGYPT COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030 (USD MILLION)
TABLE 344. EGYPT COPOVIDONE MARKET SIZE, BY FUNCTIONAL APPLICATIONS, 2018-2030 (USD MILLION)
TABLE 345. EGYPT COPOVIDONE MARKET SIZE, BY ADHESIVE BINDER, 2018-2030 (USD MILLION)
TABLE 346. EGYPT COPOVIDONE MARKET SIZE, BY FILM FORMER, 2018-2030 (USD MILLION)
TABLE 347. EGYPT COPOVIDONE MARKET SIZE, BY SOLUBILIZER, 2018-2030 (USD MILLION)
TABLE 348. EGYPT COPOVIDONE MARKET SIZE, BY PRODUCT TYPES, 2018-2030 (USD MILLION)
TABLE 349. EGYPT COPOVIDONE MARKET SIZE, BY ORAL FILM DOSAGE, 2018-2030 (USD MILLION)
TABLE 350. EGYPT COPOVIDONE MARKET SIZE, BY ORAL SOLID DOSAGE, 2018-2030 (USD MILLION)
TABLE 351. EGYPT COPOVIDONE MARKET SIZE, BY INNOVATIVE TECHNOLOGIES, 2018-2030 (USD MILLION)
TABLE 352. EGYPT COPOVIDONE MARKET SIZE, BY 3D PRINTING IN PHARMACEUTICALS, 2018-2030 (USD MILLION)
TABLE 353. EGYPT COPOVIDONE MARKET SIZE, BY NANOTECHNOLOGY ENABLED SYSTEMS, 2018-2030 (USD MILLION)
TABLE 354. FINLAND COPOVIDONE MARKET SIZE, BY FORMULATION TECHNIQUES, 2018-2030 (USD MILLION)
TABLE 355. FINLAND COPOVIDONE MARKET SIZE, BY DIRECT COMPRESSION, 2018-2030 (USD MILLION)
TABLE 356. FINLAND COPOVIDONE MARKET SIZE, BY FILM COATING, 2018-2030 (USD MILLION)
TABLE 357. FINLAND COPOVIDONE MARKET SIZE, BY HOT MELT EXTRUSION, 2018-2030

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Copovidone market report include:
  • Ashland Global Holdings Inc.
  • BASF SE
  • ChemPol Solutions
  • Clariant AG
  • Cognis Corporation
  • Colorcon, Inc.
  • Dow Chemical Company
  • DPI Corporation
  • DuoPharma International
  • Eastman Chemical Company
  • Evonik Industries AG
  • Excipio Technologies
  • Fagron NV
  • Global Excipients Group
  • InterExcipients Corporation
  • JRS Pharma Limited
  • Lonza Group AG
  • Lubrizol Corporation
  • LUCI Pharma Inc.
  • MedChemEx Industries
  • Mitsubishi Chemical Corporation
  • NexGen Polymers LLC
  • NovaChem Excipients Ltd.
  • PharmaPolymer Solutions Inc.
  • PolyMerex Inc.
  • Polysciences, Inc.
  • PrimePoly Inc.
  • Roquette Frères
  • Solvay S.A.
  • TriMed Solutions

Related Reports

Polymer Based Solubility Enhancement Excipient Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Polymer Based Solubility Enhancement Excipient Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Polymer Based Solubility Enhancement Excipients Market 2025-2029 - Product Image

Polymer Based Solubility Enhancement Excipients Market 2025-2029

  • Report
  • 233 Pages
  • Global
From
Sustained Release Excipients Market Report 2025 - Product Image

Sustained Release Excipients Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Biopharmaceutical Excipients Market - Global Forecast 2025-2030 - Product Image

Biopharmaceutical Excipients Market - Global Forecast 2025-2030

  • Report
  • 195 Pages
  • Global
From
Nutraceutical Excipients Market - Global Forecast 2025-2030 - Product Image

Nutraceutical Excipients Market - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.